Nike's Recovery Holds Challenges Despite Cost and Performance Improvements
Nike (NKE) is showing signs of improvement in key performance categories like running and basketball, but the broader recovery remains uncertain. The company's Q1 2027 earnings report revealed a 4% year-over-year decline in revenue, falling to $11.2 billion. Management expects a high-single-digit decline for the full fiscal year, with China being a notable weak spot. Despite these challenges, Nike's earnings per share (EPS) beat estimates, coming in at $0.48 compared to the $0.43 consensus.
Nike's revenue continues to shrink, particularly in China where it dropped 22% as reported and 26% on a currency-neutral basis. Converse and Nike Direct sales are also declining, raising concerns about the company's ability to rebuild momentum. While North America saw a 2% revenue increase to $5.1 billion, it's not enough to offset the broader issues. The company's TipRanks Smart Score of 1 out of 10 reflects a bearish outlook, with analysts rating it as Underperform.
On a positive note, Nike is controlling costs better, with gross margins expanding to 42.8% and inventories falling 3% to $7.8 billion. The company's Pace restructuring program aims to generate $2.5 billion in cumulative savings through Fiscal 2031. However, the dividend remains a concern, as it totals $1.64 annually, which is higher than the expected adjusted diluted EPS of $1.15 to $1.35 for Fiscal 2027. Nike has enough cash to support the payout for now, but the sustainability of the dividend is questionable given the current earnings struggles.
The stock price of $33.96 reflects skepticism, trading near the bottom of its 52-week range. While the P/E ratio of 16.2x is below the sector median, the low valuation doesn't necessarily mean the stock is cheap if earnings continue to decline. Wall Street analysts are divided, with a consensus Hold rating and an average price target of $36.47, implying roughly 7.38% upside. Despite some bright spots, the overall business hasn't caught up, leaving investors cautious about Nike's turnaround prospects.